Related Experiment Videos
Prostaglandin E2 selectively inhibits human CD4+ T cells secreting low amounts of both IL-2 and IL-4
1Research Service 151, Veterans Administration Medical Center, and Department of Medicine, University of Tennessee, Memphis, TN 38104, USA. xhe@utmem1.utmem.edu
Abstract:
PGE2 is a potent inflammatory mediator with profound immune regulatory actions. The present study examined the effects of PGE2 on the activation/proliferation of CD4+ T cells using 37 cloned CD4+ T cell lines. Ten T cell clones sensitive to PGE2 and 10 T cell clones resistant to PGE2, as measured by proliferation in response to anti-CD3 Ab, were selected for comparison. It was found that the PGE2-sensitive T cells were characterized by low production (<200 pg/ml) of both IL-2 and IL-4, while PGE2-resistant T cells secreted high levels (>1000 pg/ml) of IL-2, IL-4, or both. The roles of IL-2 and IL-4 were confirmed by the finding that addition of exogenous lymphokines could restore PGE2-inhibited proliferation, and PGE2-resistant Th1-, Th2-, and Th0-like clones became PGE2 sensitive when IL-2, IL-4, or both were removed using Abs specific for the respective lymphokines. In addition, we showed that the CD45RA expression in PGE2-sensitive T cells was significantly lower than that in PGE2-resistant cells (mean intensity, 1.2 +/- 0.6 vs 7.8 +/- 5.7; p = 0.001). In contrast, CD45RO expression in PGE2-sensitive T cells was significantly higher that that in PGE2-resistant cells (mean intensity, 55.7 +/- 15.1 vs 33.4 +/- 12.9; p = 0.02). In summary, PGE2 predominantly suppressed CD45RA-RO+ CD4+ T cells with low secretion of both IL-2 and IL-4.
Insights
Prostaglandin E2 (PGE2) suppresses CD4+ T cell proliferation, particularly in cells with low IL-2 and IL-4 production. This immune regulation involves CD45RA and CD45RO expression differences.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Prostaglandin E2 (PGE2) is a key inflammatory mediator with significant immune regulatory functions.
- CD4+ T cells play a central role in adaptive immunity, and their activation and proliferation are critical for immune responses.
Purpose of the Study:
- To investigate the impact of PGE2 on the activation and proliferation of CD4+ T cell clones.
- To identify characteristics differentiating PGE2-sensitive and PGE2-resistant CD4+ T cell populations.
Main Methods:
- Utilized 37 cloned CD4+ T cell lines, categorizing them into PGE2-sensitive and PGE2-resistant groups based on proliferation assays.
- Measured Interleukin-2 (IL-2) and Interleukin-4 (IL-4) production levels in selected T cell clones.
- Assessed the expression of CD45RA and CD45RO markers on T cells using flow cytometry.
Main Results:
- PGE2-sensitive T cells exhibited low production of IL-2 and IL-4 (<200 pg/ml), whereas PGE2-resistant cells produced high levels (>1000 pg/ml).
- Exogenous lymphokines restored proliferation in PGE2-inhibited cells, and removal of IL-2/IL-4 rendered resistant cells sensitive to PGE2.
- PGE2-sensitive T cells showed significantly lower CD45RA expression (1.2 ± 0.6) and higher CD45RO expression (55.7 ± 15.1) compared to resistant cells.
Conclusions:
- PGE2 predominantly suppresses CD4+ T cells characterized by low IL-2 and IL-4 secretion.
- CD45RA and CD45RO expression patterns are associated with differential sensitivity of CD4+ T cells to PGE2.
- The findings highlight a mechanism by which PGE2 modulates T cell responses based on their cytokine production profile and cell surface markers.